Page last updated: 2024-11-05

2,4-thiazolidinedione and Vomiting

2,4-thiazolidinedione has been researched along with Vomiting in 2 studies

thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.

Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zinman, B1
Hoogwerf, BJ1
Durán García, S1
Milton, DR1
Giaconia, JM1
Kim, DD1
Trautmann, ME1
Brodows, RG1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin[NCT00099320]Phase 3182 participants (Actual)Interventional2004-05-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for 2,4-thiazolidinedione and Vomiting

ArticleYear
The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial.
    Annals of internal medicine, 2007, Apr-03, Volume: 146, Issue:7

    Topics: Adult; Aged; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2; Double-Blind M

2007

Other Studies

1 other study available for 2,4-thiazolidinedione and Vomiting

ArticleYear
Summaries for patients. Exenatide therapy for type 2 diabetes.
    Annals of internal medicine, 2007, Apr-03, Volume: 146, Issue:7

    Topics: Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Exenatide; F

2007